Bone marrow transplant retinopathy
- PMID: 1957898
- DOI: 10.1016/s0002-9394(14)77269-1
Bone marrow transplant retinopathy
Erratum in
- Am J Ophthalmol 1992 May 15;113(5):616
Abstract
Five of eight patients (62%) who survived at least six months after autologous or allogeneic bone marrow transplantation for acute leukemia developed occlusive microvascular retinopathy. Treatable retinal microangiopathy included a high incidence (80%) of clinically significant macular edema and one case of proliferative retinopathy with subhyaloid hemorrhage. The bone marrow transplant protocol required high-dose cytarabine hydrochloride and 1,200 cGy of total body irradiation. The development of radiation retinopathy after such low doses of teletherapy suggests that high-dose chemotherapy may increase the susceptibility for the development of retinopathy at otherwise safe radiation doses.
Comment in
-
Bone marrow transplant retinopathy.Am J Ophthalmol. 1992 May 15;113(5):604-5. doi: 10.1016/s0002-9394(14)74751-8. Am J Ophthalmol. 1992. PMID: 1637410 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical